GTC Biotherapeutics - GTC Biotherapeutics in the News


	2010 PRESS RELEASE ARCHIVE July 27, 2010 - GTC Biotherapeutics Reports Second Quarter 2010 Financial Results July 20, 2010 - GTC Biotherapeutics to Host Second Quarter 2010 Earnings Call and Webcast on Tuesday, July 27, 2010 July 16, 2010 - GTC Biotherapeutics Regains US Rights to ATryn® ; the First Recombinant Antithrombin Product Approved in the World June 16, 2010 - GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes May 12, 2010 - GTC Biotherapeutics Reports First Quarter 2010 Financial Results April 13, 2010 - GTC Enters Atryn® Registration License with Bio Sidus Argentina March 12, 2010 - GTC Biotherapeutics Reports Fourth Quarter and Fiscal Year End 2009 Financial Results March 12, 2010 - GTC Biotherapeutics Reports Fourth Quarter and Fiscal Year End 2009 Financial Results March 10, 2010 - GTC Biotherapeutics to Webcast Corporate Presentation at the ROTH 22nd Annual OC Growth Stock Conference March 5, 2010 - GTC Biotherapeutics to Host Fourth Quarter and Year End 2009 Earnings Call and Webcast on Friday, March 12, 2010 March 1, 2010 - GTC Provides Update on TG20 Monoclonal Antibody Targeting CD20 February 22, 2010 - GTC Enters into Agreement to Receive $7 Million in Financing from LFB February 3, 2010 - GTC Biotherapeutics to Webcast Corporate Presentation at the 12th Annual BIO CEO & Investor Conference January 28, 2010 - GTC Provides Recombinant FVIIa Regulatory Update January 8, 2010 - GTC Announces Conversion of LFB’S Preferred Stock into Common Shares and Provides a Portfolio Update
	Copyright 2010 GTC Biotherapeutics, All Rights Reserved